Symposium 1
EXPERIMENTAL ANIMALS · 2019
Recent developments in biotechnology have contributed to the increase in the amounts of high-throughput data for compounds and proteins in the genome, transcriptome, proteome, metabolome and phenome. These biomedical big data can be useful resources for drug discovery and repositioning. Drug repositioning, or the identification of new drug indications (new applicable diseases of existing drugs), is an efficient strategy for drug development. The drug repositioning approach has received remarkable attention in medical and pharmaceutical research.